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Abstract
Background: Controversy remains whether a pattern of cervical intraepithelial neoplasia exists on the cervix. Our
study aims at determining if the prevalence of histologically proven lesions differs by cervical four-quadrant location
or by 12 o'clock surface locations of diagnosis.
Methods: We conducted a retrospective, histopathological study of 19 different population based cervical cancer
screening studies from 1999 to 2010 by Cancer Hospital of Chinese Academy of Medical Sciences. The Institutional
Review Board for human research subjects at CHCAMS approved all of the studies. During the colposcopy
procedure, participant received either 4-quadrant biopsy or directed biopsy with/without endocervical curettage.
Data of all samples were stratified by the methods of sampling. Kruskal-Wallis test was used to determine overall
distribution of normal/CIN1, CIN2 and CIN3+ on the cervix.
Results: In total, 53,088 cervical samples were included in distribution analysis. 66.9 % samples were obtained by
random biopsy, 16.1 % were by directed biopsy, and 17.0 % were by endocervical curettage. 95.9%of the biopsied
samples were diagnosed as normal/CIN1, 2.0 % were CIN2, and 2.1 % were CIN3 + . CIN2 and CIN3+ were most
often found in quadrants 2 and 3 (χKW2 = 46.6540, p < 0.0001) and at the 4- and 7-o'clock positions by directed
biopsy (ORCIN2 = 2.572, 1.689, ORCIN3+ = 3.481, 1.678, respectively), and at the 5-, 6-, 7-, 9- and 12-o’clock positions by
random biopsy. CIN3+ was least often found at the 11-o’clock position by directed biopsy (OR = 0.608).
Conclusions: Our results suggest a predisposition of specific locations on the cervix to CIN occurrence. Quadrants 2
and 3, especially the 4- and 7-o’clock positions should be preferentially targeted during biopsy. The decision for
random biopsy should be reconsidered in future studies.
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Background
Persistent infection with high risk human papillomavirus
(hr-HPV) has been established as the major etiological
factor for cervical intraepithelial neoplasia (CIN) [1–3].
Early detection of precursor lesions is imperative be-
cause without treatment, all grades of CIN may progress
to invasive cervical cancer, although CIN 1 lesions
progress less frequently [4, 5]. Carcinogenesis occurs
within the transformation zone of the cervix, where
primary screening methods such as the Papanicolaou
(Pap) smear detect early cytological abnormalities [4, 6].
Definitive diagnosis of CIN is obtained through colpos-
copy with biopsy and histopathology [7–10].
Colposcopy with directed biopsy is the current gold
standard for diagnosis of pre-invasive cervical cancer,
with sensitivity up to 84.8 % for high-grade squamous
intraepithelial lesions or worse (HSIL+) [11]. Despite its
high accuracy and concordance with histology, colpos-
copy technique remains largely operator-dependent with
no standardized guidelines [12–14]. To address the
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practitioner-dependent limitations of colposcopically di-
rected biopsy, colposcopists are recommended to obtain
additional random biopsies from distinct locations, and
to perform endocervical curettage (ECC) in women with
ambiguous pap smears or women over 45 years old with
suspected high-grade lesions [15–17].
Controversy exists in literature on whether there is a
topographical pattern of CIN on the cervix that could be
targeted by colposcopy [18–24]. The cervix is often
identified by clockwise, using the o’clock position with
the 12 o’clock and the 6 o’clock position being located at
the midpoint of the anterior and posterior lip of the
cervix, the 3 o’clock and 9 o’clock position located at the
midpoint of the right and left side, respectively. Some
researchers reported a predilection of histologically
confirmed CIN loci for the anterior and posterior cer-
vical os [18–21]. He et al. suggests that CIN lesions are
not randomly distributed, but concentrated in the 12-,
8-, and 7-o’clock sites on the cervix [18]. Allard et al and
Heatley M reported a predilection for the locations on
anterior and posterior lips of the cervix [19, 20]. Richart
claimed CIN occurs more frequently on the anterior lip
of the cervix than on the posterior [21]. However, Yang
HP et al have not found preferential sites on the cervix
for CIN3 [22]. Besides, there are also some studies re-
port heterogeneity in CIN occurrence across the cervix,
but claiming the evidence maybe confounded by some
factors, such as a tendency of the anterior and posterior
lips to look more acetowhite, the inherent imprecision
of colposcopy and operator bias for anterior-posterior
cervical sampling due to mechanical ease [23, 24]. Clini-
cians were recommend to take multiple random biopsies
during colposcopy in all cervical quadrants even without
visible lesions to avoid missing CIN invisible to the
naked eye [15, 16], a possible existing predilection distri-
bution of CINs on the cervix may help the clinicians to
make decisions while performing random biopsy. Since
controversy still remains, our study aims to determine if
the prevalence of histologically proven CIN lesions
differs by cervical 4-quadrant location or by 12-o’clock
location of diagnosis on the cervix. These findings may
help in the development of colposcopy guidelines.
Method
Population
We conducted a retrospective, pooled data analysis of 19
different population based screening studies conducted
by the Cancer Hospital, Chinese Academy of Medical
Sciences (CHCAMS) in Beijing, China. We determined
the distribution of CIN 2+ lesions among 38,633 women
participating in studies from 1999 to 2010 listed in
Additional file 1 a (i.e, Shanxi Province Cervical
Cancer Screening Study(SPOCCS) I (1999), SPOCCS II
(2001-2002), SPOCCS III-1-5 (2006-2007), Screening
Technologies to Advance Rapid Testing(START) 2003,
2004, 2005, 2006, 2007, Screening Technologies to
Advance Rapid Testing—Utility and Program Planning
(START-UP) 2010, cooperative screening studies with
International Agency for Research on Cancer(IARC) I, II
and III, FastHPV trial (2007), Prevalence survey (2008),
and Hybrid Capture (HC) 2 trial (2008)). The Institutional
Review Board for human research subjects at CHCAMS
approved all these studies prior to commencing. Written
informed consent was obtained from all women. Study
procedures and methodology have been described previ-
ously [25, 26].
Participants who were biopsied in all studies were
between 19 to 65 years old, not pregnant, and had no
history of pelvic surgery or irradiation. In colposcopy,
the surface of the cervix divided by perpendicular lines
drawn from 12- to 6- o’clock and from 3- to 9-o’clock.
The four cervical quadrants are labeled clockwise, with
quadrant 1 from 12 to 3 o’clock, quadrant 2 from 3 to 6
o’clock, quadrant 3 from 6 to 9 o’clock, and quadrant 4
from 9 to 12 o’clock. Screened women included in our
analysis had at least one positive result on various
cervical cancer screening tests (Additional file 1), except
for women in the SPOCCS I trial which all participants
underwent 4-quadrant biopsy and ECC regardless of
their screening results and in START-UP study that
10 % of all primary screening negative women under-
went colposcopy and 4-quadrant random biopsy and
ECC. After being referred to colposcopy, according to
the proposals (SPOCCS II, SPOCCS III, START 2003-
2007), participants received colposcopically directed
biopsy in any abnormal-appearing area and random bi-
opsy in other negative quadrants at the squamocolumnar
junction around 2-, 4-, 8-, and 10-o’clock so that partici-
pants in these studies referred to colposcopy had a mini-
mum of 4 quadrants biopsies. In other studies (Prevalence
study, HC2 trial, FastHPV trial and IARC 1-3), partici-
pants received directed biopsy at the positive colpscopy
quadrant only or 4-quadrant biopsy were performed at
the squamocolumnar junction if the colposcopy diagnosis
were negative. ECC was subsequently performed accord-
ing to study protocols. The indications for colposcopically
directed biopsies were the same across the studies that
any abnormal-appearing areas should be targeted, includ-
ing suspicious HPV infection or low-grade lesions. The
quadrants and/or o’clock location were required to be re-
corded by the operators. Only participants with complete
biopsy records and pathological diagnoses were included.
Samples with incomplete data, unsatisfactory biopsies,
and biopsies with ambiguous diagnoses or non-specific
labeling of location of origin (e.g., “close to 6 o’clock”,
“between 2 and 3 o’clock”) were excluded. Cases with only
quadrant but no o’clock data were included in the 4-
quadrant analysis and excluded from the 12 o’clock
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location analysis. In studies with international collabora-
tors, final diagnosis was based on the international pathol-
ogist’s read. In domestic studies, the final diagnosis was
established by simple majority consensus among readings
by three separate pathologists.
Statistical analysis
Data of all samples were stratified into three groups
based on method of colposcopic sampling – random bi-
opsy, directed biopsy, or ECC, and analyzed using
SAS9.2 software. Kruskal-Wallis test was used to deter-
mine overall distribution of normal/CIN1, CIN2 and
CIN3+ on the cervix with statistical significance set at
p < 0.05. Chi-square test was used to compare the
difference of rates. Occurrence of cervical lesions was
grouped by quadrants, then by 12 o’clock location.
Differences in CIN distribution by quadrants and by
o’clock location were analyzed using the Kruskal-
Wallis test at the level of adjusted α’. The adjusted α1
for quadrant location was 0.0083 and α2 for o’clock lo-
cation was 0.00075 respectively. Adjusted α values were
calculated by the Bonferroni test (α’ = α/ [k*(k-1)/2], α =
0.05)). The 10 o’clock location, which had the relatively
lower frequency of CIN occurrence, was used as the refer-
ence point of comparison for CIN occurrence in other
o’clock locations.
Results
In total, 38,633 women participated in the 19 screening
studies. Of these 38,633 women, 12,656 were referred to
colposcopy with biopsy and/or ECC. Participants with
quadrants biopsies and/or ECC and a pathological diag-
nosis were included. Among the 12,656 women, 199 of
them were excluded since biopsied only on polyps or
missing data; 9001 women received four-quadrant biop-
sies and ECC; 1089 women received 4-quadrant biopsies
without ECC; 283 women received one to three quad-
rants biopsies with ECC; 2013 women received one to
three quadrants biopsy without ECC and 71 women had
ECC only.542 women were diagnosed as CIN2, 484
CIN3 and 64 cervical cancer cases.
The sociodemographic data of participants received
biopsy are shown in Table 1. Mean age was 41.5 with an
average of 3 pregnancies, 2.3 live births, and an average
of 1.5 lifetime sexual partners. Of the total 53,592 histo-
pathology samples obtained, 382 samples were diag-
nosed as unsatisfactory or others. 122 samples lost
information of biopsied type, among them, 4 CIN3 or
worse (CIN3+), 6 CIN2 and 112 CIN1/Normal. 53,088
samples were included in distribution analysis. 95.9 %
(50,912/53,088) of biopsied specimens were diagnosed as
normal/CIN1, 2.0 % (1074/53,088) were CIN2, and 2.1 %
(1102/53,088) were CIN3+. CIN2 or worse (CIN2+)
lesions constituted 4.1 % (2176/53,088) of the total cases.
66.9 % (35,508/53,206) samples were obtained by ran-
dom biopsy, 16.1 % (8538/53,088) were by directed
biopsy, and 17.0 % (9042/53,206) were by ECC. Of the
44,046 samples obtained by quadrants biopsy, 2.2 %
(973/44,046) were found to be CIN2 and 2.1 % (927/
44,046) were found to be CIN3+. The positive rate of
CIN2+ lesions by directed biopsy (14.1 %, 1201/8538) or
random biopsy (2.0 %, 699/35,508) showed statistical
significance (χ2 = 2440.635, p < 0.0001).
Of the 9042 samples obtained by ECC, 1.1 % of them
(101/9042) were found to be CIN2 and 1.9 % (175/9042)
were found to be CIN3+. The distribution difference of
CIN2+ lesions by quadrants biopsy and ECC is statistical
significant (4.3 % vs. 3.1 %, OR = 1.4318, χ2 = 30.3592,
p < 0.001).
Table 1 Demographics of 12,656 biopsied participants
Mean ± SD Median (Range)
Age in years 41.5 ± 7.2 41 (19-65)
Age at menarche in years 15.7 ± 1.9 16 (10-26)
Sexual history
Age at sexual debut in years 20.9 ± 2.3 21 (13-37)
Number of pregnancies 3.0 ± 1.3 (0-16)
Number of live births 2.3 ± 1.0 (0-14)
Number of sexual partners 1.5 ± 1.2 (0-40)
Number (n) Percentage (%)
Marital status
Single 34 0.30 %
Married 12081 96.10 %
Widowed 235 1.90 %
Divorced 77 0.60 %
Education level
<Primary school 1262 10.00 %
Primary school 4055 32.20 %
Middle school 6088 48.40 %
High school or above 1027 8.20 %
Current contraceptiveuse
Yes 11510 91.50 %
Contraceptive method
Oral contraceptive pill 269 2.30 %
Condom 473 4.10 %
IUD 3476 30.20 %
Sterilization 8913 77.40 %
Smoking history
Never smoked 12061 95.90 %
Quit smoking 40 0.30 %
Current smoker 271 2.20 %
SD standard deviation; IUD intrauterine device
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The distribution frequency of CINs by cervical loca-
tion of all women, grouped by method of biopsy is
summarized in Table 2.
Overall, CIN2+ lesions were significantly more fre-
quently found in the posterior cervix (second and third
quadrants, n = 1022) than in the anterior cervix (first
and fourth quadrants, n = 878, χ2 = 15.556, p < 0.0001).
When the cervix was divided in half on a sagittal plane,
there was no significant difference in CIN2+ occurrence
between the left (third and fourth quadrants, n = 970)
and the right sides (first and second quadrants, n = 930,
χ2 = 0.994, p = 0.319). By directed biopsy, CIN2 and
CIN3+ lesions were significantly more likely to be found
in the second and third quadrants than in the first and
fourth quadrants (χKW
2 = 46.6540, p < 0.0001). CIN2
lesions obtained by directed biopsy were significantly
Table 2 Distribution frequency of normal/CIN1, CIN2, and CIN3 + lesions by method of biopsy, grouped by cervical quadrant
location
Quadrants Diagnosis
Normal/CIN1 CIN2 CIN3+ Total
n n/Nr(%) 95%CI n n/Nr(%) 95%CI n n/Nr(%) 95%CI Nr Nr/N(%)
Directed biopsy
Q1 1968 88.1 86.7 89.4 129 5.8 4.9 6.8 136 6.1 5.2 7.1 2233 4.2
Q2 1583 83.2 81.5 84.8 167 8.8 7.6 10.1 153 8.0 6.9 9.3 1903 3.6
Q3 1548 82.8 81.1 84.5 146 7.8 6.7 9.1 175 9.4 8.1 10.8 1869 3.5
Q4 2238 88.4 87.1 90.0 126 5.0 4.2 5.9 169 6.7 5.7 7.7 2533 4.8
P < 0.0001
Random biopsy
Q1 8698 98.2 97.9 98.5 87 1.0 0.8 1.2 72 0.8 0.6 1.0 8857 16.7
Q2 8873 97.9 97.6 98.2 106 1.2 1.0 1.4 80 0.9 0.7 1.1 9059 17.1
Q3 8717 97.8 97.5 98.1 118 1.3 1.1 1.6 77 0.9 0.7 1.1 8912 16.8
Q4 8521 98.2 97.9 98.4 94 1.1 0.9 1.3 65 0.7 0.6 0.9 8680 16.4
P = 0.1911
ECC
8766 96.9 96.6 97.3 101 1.1 0.9 1.4 175 1.9 1.7 2.2 9042 17.0
Total 50912 95.9 95.7 96.1 1074 2.0 1.9 2.1 1102 2.1 2.0 2.2 53088 100.0
CIN cervical intraepithelial neoplasia; Q quadrant; ECC endocervical curettage; CI confidence interval
Fig. 1 Frequency of normal/CIN1, CIN2, and CIN3+ by cervical quadrants, group by method of biopsy
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more likely to be found in the second and third quadrants
(n = 313) than in the first and fourth quadrants (n = 255),
(χKW
2 = 35.3607, p < 0.0001). CIN3+ lesions were also sig-
nificantly more frequently found in the second or the third
quadrant (n2 = 153, n3 = 175) than in the first or fourth
quadrant (n1 = 136, n4 = 169), (χKW
2 = 22.4373, p < 0.0001).
No significant differences in quadrant distribution were
found for CIN2 and CIN3+ lesions obtained by random
biopsy (χKW
2 = 4.7494, p = 0.1911).
Figure 1 shows the distribution frequency of CIN
lesions by cervical quadrant location and grouped by
method of biopsy of all the cervical samples.
Of the 53,088 samples included, the information of 12
o’clock location was not recorded for 11,594 samples,
107 samples without definite location information, so
that 41,387 samples were included in clock location ana-
lysis. The distribution frequency of CIN by 12 o’clock lo-
cation and grouped by method of biopsy is presented in
Table 3. In both random and directed biopsy, there was
a statistically significant pattern of CIN occurrence on
the cervix (χKWd
2 = 54.3880, χKWr
2 = 73.1819, p < 0.0001).
By directed biopsy, CIN2+ lesions were most likely to
occur at the 4- (odds ratio, OR = 2.572, 95 % Confidence
interval, 95 % CI: 1.900, 3.481) and 7- (OR = 1.689, 95 %
CI: 1.211, 2.355) o’clock positions. The CIN3+ lesions
were most likely to occur at 4- and 7-o’clock positions as
well, the ORs are 2.959 (95 % CI: 2.026, 4.323) and 1.678
(95 % CI: 1.095, 2.572) respectively. By random biopsy,
Table 3 Distribution frequency of normal/CIN1, CIN2, and CIN3 + lesions by method of biopsy, grouped by 12 o’clock cervical
location
O’clock location Diagnosis
Normal/CIN1 CIN2 CIN3+ Total ORCIN2+ 95 % CI ORCIN3+ 95 % CI
n n/Nr(%) n n/Nr(%) n n/Nr(%) Nr Nr/N(%)
Directed biopsy
1 728 91.8 35 4.4 30 3.8 793 13.1 0.775 0.547 1.098 0.624 0.387 1.006
2 391 86.3 26 5.7 36 7.9 453 7.5 1.376 0.961 1.971 1.394 0.880 2.209
3 168 91.3 6 3.3 10 5.4 184 3.0 0.827 0.470 1.456 0.901 0.444 1.831
4 486 83.6 49 8.4 95 7.9 581 9.6 2.572 1.900 3.481 2.959 2.026 4.323
5 436 88.4 26 5.2 31 6.3 493 8.1 1.135 0.788 1.635 1.076 0.668 1.735
6 319 90.9 15 4.2 17 4.8 351 5.8 0.871 0.564 1.345 0.807 0.045 1.437
7 442 83.7 37 7.0 49 9.3 528 8.7 1.689 1.211 2.355 1.678 1.095 2.572
8 553 88.5 41 6.6 31 5.0 625 10.3 1.130 0.802 1.592 0.849 0.528 1.365
9 138 87.9 7 4.5 12 7.6 157 2.6 1.195 0.699 2.042 1.317 0.677 2.562
10 651 89.7 32 4.4 43 5.9 726 12.0 1 / / 1 / /
11 672 92.1 31 4.2 27 3.7 730 12.0 0.749 0.523 1.073 0.608 0.372 0.996
12 405 91.6 16 3.6 21 4.8 442 7.3 0.793 0.525 1.198 0.785 0.459 1.342
Total 5389 88.9 321 5.3 353 5.8 6063 100.0
Random biopsy
1 276 96.8 6 2.1 3 1.1 285 0.8 1.829 0.923 3.623 1.508 0.470 4.841
2 8321 98.3 80 0.9 67 0.8 8468 24.0 0.991 0.786 1.248 1.117 0.786 1.588
3 46 95.8 0 0.0 2 4.2 48 0.1 2.438 0.586 10.139 6.033 1.431 25.431
4 8646 98.1 94 1.1 74 0.8 8814 25.0 1.090 0.871 1.363 1.188 0.843 1.674
5 117 92.1 6 4.7 4 3.2 127 0.4 4.793 2.462 9.330 4.744 1.695 13.277
6 73 93.6 4 5.1 1 1.3 78 0.2 3.841 1.530 9.644 1.901 0.260 13.904
7 134 93.1 5 3.5 5 3.5 144 0.4 4.185 2.156 8.121 5.178 2.046 13.106
8 8488 97.9 108 1.2 70 0.8 8666 24.5 1.176 0.943 1.467 1.144 0.808 1.620
9 46 93.9 3 6.1 0 0.0 49 0.1 3.657 1.125 11.893 0 0 0
10 8187 98.2 87 1.0 59 0.7 8333 23.6 1 / / 1 / /
11 208 96.7 4 1.9 3 1.4 215 0.6 1.887 0.873 4.079 2.001 0.622 6.436
12 91 93.8 3 3.1 3 3.1 97 0.3 3.697 1.593 8.583 4.575 1.408 14.861
Total 34633 98.0 400 1.1 291 0.8 35324 100.0
CIN cervical intraepithelial neoplasia; OR odds ratios; CI confidence intervals
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CIN2+ lesions were more likely to occur at the 5- (OR =
4.793, 95 % CI: 2.462, 9.330), 6- (OR = 3.841, 95 % CI:
1.530, 9.644), 7- (OR = 4.185, 95 % CI: 2.156, 8.121), 9-
(OR = 3.657, 95 % CI: 1.125, 11.893), and 12-(OR =
3.697, 95 % CI: 1.593, 8.583) o’clock positions. CIN3+
lesions were more likely to occur at the 3- (OR = 6.033,
95 % CI: 1.431, 25.431), 5- (OR = 4.744, 95 % CI: 1.695,
13.277), 7- (OR = 5.178, 95 % CI: 2.046, 13.106) and 12-
(OR = 4.575, 95 % CI: 1.408, 14.861) o’clock positions. A
visual representation of the topographical distribution
and severity of CIN on the cervix is shown in Fig. 2.
Discussion
The goal of colposcopy is to identify suspected high-grade
lesions on the cervix and to rule out subclinical (or pre-
clinical) invasive cancer. Ambiguity occurs in defining ap-
propriate colposcopy practices and biopsy site selection,
which leads to inaccurate diagnosis and treatment. Our
study demonstrates significant distribution frequency of
CIN2+ lesions on the cervix by quadrants, which may
help colposcopists target specific regions on the cervix to
obtain additional biopsies. CIN2 and CIN3+ lesions ob-
tained by directed biopsy were more commonly found on
the posterior two quadrants (quadrants 2 and 3). Previous
studies have demonstrated increased CIN2+ diagnoses at
the posterior cervix compared to the anterior [18]. Preto-
rius et al. also found a slightly increased prevalence of
CIN2+ in the posterior cervix, which they attributed to
verification bias [24]. Since specificity of colposcopy was
not assessed in our present study, we are unable to draw
conclusions about whether verification bias was present.
The distribution frequency of CIN lesions in our study is
not likely due to colposcopist preference for oversampling
the anterior and posterior cervix due to mechanical ease
[19, 22, 27], as approximately equal numbers of biopsies
were taken from each quadrant, the opportunity to detect
CIN2+ lesions in these quadrants should be equal. It is
possible that with the greatly increased sample size in our
study detected a true clinical difference in CIN2+ preva-
lence by cervical 4-quadrant location. Percentage of
CIN2+ diagnoses was also significantly higher in quad-
rants 2 and 3 compared to quadrants 1 and 4, implying
that independently of presence and grade of disease, lo-
cation plays a role in lesion severity.
There was also significant frequency of CIN distribu-
tion by 12-o’clock location, further supporting that the
specific points on the cervix may be predisposed to CIN
growth. By directed biopsy, CIN2+ lesions were most
likely to occur at the 4- and 7-o’clock positions, and least
likely at the 11-o’clock position. This finding is consist-
ent with He et al’s study, which found the most severe
lesions at the 7- and 8-o’clock locations. While the 12-
o’clock location was found to be the most common for
CIN2+ lesions in both our studies, we found 11-o’clock
instead of 2-o’clock as the least common location.
Although the results of directed biopsies taken from
12 o’clock cervical locations show non-random distribu-
tion of the lesions is reliable, we also noticed that no
statistical significance was found by random biopsy in
quadrants. This may be due to the increased diagnostic
accuracy of directed biopsy for CIN2+ in larger, visible
lesions [27] and only colposcopy invisible lesions would
be found by random biopsy, causing the low detection
rate of CIN2+ lesions by biopsy targeting normal-
appearing areas [28], which in our study is 2.0 %. It is
possible that since most random biopsy at normal-
appearing areas performed at 2-, 4-, 8-, 10-o’clock,
possible invisible lesions on the perpendicular midline of
the cervix might be missed, which is the finding by di-
rected biopsy in our study and also other researchers
[18–21]. This may be an explanation to the low detec-
tion rate of CIN2+ lesion by random biopsy in our
screening studies as well. By random biopsy, CIN2+ le-
sions were more likely to occur at the 5-, 6-, 7-, 9- and
12-o’clock positions rather than 2-, 4-, 8-, 10-o’clock.
Considering this and the findings of directed biopsy, the
decision on the positions for random biopsy should be
reconsidered in future studies.
Strengths of this study are the large sample size, broad
age range of participants, detailed labeling of biopsy lo-
cation, rigorous methodology, and high level of diagnos-
tic quality control based on three separate pathologist
readings. Our aggregate results on the location and
histopathological diagnosis of 53,088 cervical samples
represent the most comprehensive analysis of CIN distri-
bution frequency to date. Regardless of method of bi-
opsy, there was an increased frequency of CIN2+ lesions
on the posterior midline cervix. Possible etiology of the
predilection of CIN for the anterior and posterior cervix
may be twofold. First, mechanical trauma to the anterior
and posterior cervix during intercourse, combined with
Fig. 2 Topographical distribution of CIN2+ lesions by quadrant and
12-o’clock cervical location
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decreased blood flow and pooling of fluids and sloughed
squamous epithelium in the anatomical recesses may
lead to lower viral clearance in the anterior and poster-
ior fornices [23, 29]. Secondly, squamous transformation
of the anterior and posterior lips of the cervix occurs
later in embryological development than the lateral
sides, allowing more time for malignant potential [23].
The squamocolumnar junction is formed by mesenchy-
mal induction caudally, leaving some residual Wolffian
duct segments within the endocervical stroma. This
epithelial-mesenchymal transition process has been im-
plicated in cervical carcinogenesis, which could explain
CIN predominance in the posterior cervix [30, 31].
Weaknesses of this study are the retrospective design
and non-uniform number of biopsies conducted at each
of the 12 o’clock points on the cervix due to the inherent
imprecision in colposcopy. However, clinicians in our
study obtained comparable number of biopsies by quad-
rant. Women in our study were older and multiparous,
limiting the generalizability of our findings to younger,
low-risk populations. Future prospective studies on cer-
vical conization samples may reveal the true distribution
of CIN lesions. Randomized prospective studies compar-
ing the diagnostic outcomes of women with additional
biopsies taken from sites with greater CIN frequency
may confirm our findings and evaluate if targeting
certain sites, such as the perpendicular midline of the
cervix for normal-appearing areas increases the detec-
tion rate of CIN lesions.
Conclusions
The distribution pattern of CIN2+ lesions identified in
our study has important implications for future screen-
ing and clinical management of precancerous cervical
lesions. In the event of diffuse or equivocal changes in
the cervix, Quadrants 2 and 3, especially the 4- and 7-
o’clock positions should be preferentially targeted during
biopsy as this may increase diagnostic accuracy. The
decision on the position for random biopsy should be
reconsidered in future studies.
Additional file
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